vedolizumab
takeda
['vedolizumab', 'ibd', ' vedo']
on the final day of #uegweek22 we have two fantastic presentations! first with present her work on molecular response on vedolizumab then will present her work on cell-specific responses in different ibd treatments. join us!
The Rosenstiel lab @IKMB studies inflammatory bowel disease (#IBD). Passion for #organoids, #microbiome, systems #immunology, #NGS and #singlecell